Alpha DNA Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$2.53M |
| 2 |
Morgan Stanley
MS
|
+$2.23M |
| 3 |
Colgate-Palmolive
CL
|
+$2.21M |
| 4 |
TJX Companies
TJX
|
+$1.81M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$1.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.62M |
| 2 |
McDonald's
MCD
|
+$2.54M |
| 3 |
Mondelez International
MDLZ
|
+$2.52M |
| 4 |
Cigna
CI
|
+$2.32M |
| 5 |
JPMorgan Chase
JPM
|
+$2.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.39% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 9.82% |
| 4 | Consumer Discretionary | 6.3% |
| 5 | Industrials | 6.08% |
Similar funds
Alpha DNA Investment Management's Q2 2024 Portfolio in Review
As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.
- Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
- Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
- Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
- Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
- Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
- Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
- Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.
Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.